Technical Analysis for MLND - Millendo Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 2.505 -5.83% -0.16
MLND closed up 34.34 percent on Friday, May 29, 2020, on 5.58 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical MLND trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish -5.83%
180 Bullish Setup Bullish Swing Setup -5.83%
Expansion Pivot Buy Setup Bullish Swing Setup -5.83%
Pocket Pivot Bullish Swing Setup -5.83%
Volume Surge Other -5.83%
Wide Range Bar Range Expansion -5.83%
Parabolic Rise Strength -5.83%
Stochastic Reached Overbought Strength -5.83%
Upper Bollinger Band Walk Strength -5.83%
Weak + Overbought Other -5.83%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Millendo Therapeutics is a late-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases where current therapies do not exist or are insufficient. The Company’s objective is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of endocrine diseases where there is a significant unmet medical need. The Company is currently advancing livoletide for the treatment of Prader-Willi syndrome and nevanimibe for the treatment of classic congenital adrenal hyperplasia and endogenous Cushing’s syndrome.
Organ Systems Endocrine System Late Stage Biopharmaceutical Cushing's Syndrome Adrenal Gland Disorders Congenital Adrenal Hyperplasia Endocrine Diseases Prader Willi Syndrome

Is MLND a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.99
52 Week Low 1.26
Average Volume 1,237,250
200-Day Moving Average 6.10
50-Day Moving Average 2.63
20-Day Moving Average 1.86
10-Day Moving Average 2.00
Average True Range 0.27
ADX 24.5
+DI 37.22
-DI 14.43
Chandelier Exit (Long, 3 ATRs ) 1.96
Chandelier Exit (Short, 3 ATRs ) 2.35
Upper Bollinger Band 2.33
Lower Bollinger Band 1.39
Percent B (%b) 1.35
BandWidth 50.46
MACD Line -0.08
MACD Signal Line -0.24
MACD Histogram 0.1621
Fundamentals Value
Market Cap 94.93 Million
Num Shares 35.7 Million
EPS -2.11
Price-to-Earnings (P/E) Ratio -1.26
Price-to-Sales 116.65
Price-to-Book 0.67
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.85
Resistance 3 (R3) 3.75 3.26 3.65
Resistance 2 (R2) 3.26 2.96 3.31 3.58
Resistance 1 (R1) 2.96 2.77 3.11 3.06 3.52
Pivot Point 2.47 2.47 2.55 2.52 2.47
Support 1 (S1) 2.17 2.17 2.32 2.27 1.80
Support 2 (S2) 1.68 1.98 1.73 1.74
Support 3 (S3) 1.38 1.68 1.67
Support 4 (S4) 1.48